Dr Muneeb Faiq, an alumnus of Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, has been named the Emerging Vision Scientist – 2019 in the United States. He was nominated for this recognition for his innovative research on glaucoma.
Glaucoma is a leading cause of irreversible blindness worldwide with approximately 80 million sufferers. This is a devastating disorder for which there is no cure and the only available treatment is lowering of the eye pressure with medication and/or surgery.
Dr Muneeb Faiq was one of those innovative young scientists from across the United States selected to participate in the fifth annual Emerging Vision Scientists Day hosted by National Alliance for Eye and Vision Research at the Capitol Hill in Washington DC.
As Emerging Vision Scientists, these innovative vision researchers got an opportunity to present their research to members of Congress and their staffs at a reception on 18th and 19th September 2019.
It is pertinent to mention that back in 2014, Dr Muneeb Faiq proposed brain insulin dysfunction as one of the cardinal features of glaucoma. Earlier this year, he presented the initial experimental evidence of this hypothesis at the annual meeting of the Association for Research on Vision and Ophthalmology held in Vancouver, Canada.
Owing to his outstanding contribution to vision sciences and brain basis of glaucoma, Dr Muneeb Faiq was awarded the Best Doctorate Scholar award at AIIMS in 2015.
With support from Dr Kevin Chan, PhD, Director of the Neuroimaging and Visual Science Laboratory at NYU Langone Health, New York, USA, Dr Muneeb Faiq focuses on the brain basis of glaucoma and aims at deciphering the role of brain insulin signalling in intraocular pressure regulation and optic nerve degeneration.
Combining these techniques with MRI and visual behaviour, their research has a potential to provide further insight into the neurodegenerative mechanisms of glaucoma and identify novel therapies and therapeutic targets for this devastating disorder.
Dr Muneeb Faiq is involved in basic as well as clinical research that could be employed to bridge the gap between bench and bedside.